CDKN2D Antikörper
CDKN2D
Reaktivität: Human
IHC, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2148238
-
-
Target
Alle CDKN2D Antikörper anzeigen
-
CDKN2D
(Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser CDKN2D Antikörper ist unkonjugiert
-
Applikation
-
Immunohistochemistry (IHC), ELISA
-
Aufreinigung
-
Purified
-
Immunogen
-
P19 INK4d antibody was raised in Rabbit using synthesized peptide derived from internal of human P19 INK4d as the immunogen
-
Isotyp
-
IgG
-
Top Product
-
Discover our top product CDKN2D Primärantikörper
-
-
-
Applikationshinweise
-
IHC: 1:50-1:100, ELISA: 1:40000
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Konzentration
-
Lot specific
-
Buffer
-
PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store in small aliquots at -20 °C
-
-
Target
-
CDKN2D
(Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Andere Bezeichnung
-
P19 INK4d (CDKN2D Produkte)
-
Synonyme
-
ink4d antikoerper, p19 antikoerper, p19-ink4d antikoerper, CDKN2D antikoerper, ank2 antikoerper, INK4D antikoerper, p19-INK4D antikoerper, INK4d antikoerper, p19INK4d antikoerper, cyclin-dependent kinase inhibitor 2D S homeolog antikoerper, cyclin dependent kinase inhibitor 2D antikoerper, cyclin-dependent kinase inhibitor 2D antikoerper, Cyclin-dependent kinase 4 inhibitor D antikoerper, cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) antikoerper, similar to cyclin-dependent kinase inhibitor 2D antikoerper, cdkn2d.S antikoerper, CDKN2D antikoerper, cdkn2d antikoerper, cdn2d antikoerper, Cdkn2d antikoerper
-
Pathways
-
Zellzyklus, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling
-